Literature DB >> 16807523

Stimulation of the hippocampal glutamate receptor systems induces stress-like responses.

Hiroyuki Umegaki1, Aki Yamamoto, Yusuke Suzuki, Akihisa Iguchi.   

Abstract

OBJECTIVE: The hypothalamic-pituitary-adrenal (HPA) axis controls glucocorticoid secretion and is in turn controlled by a diverse set of afferents in the brain. However, the precise mechanisms underlying these actions remain to be elucidated. In our previous study, a lesion in the entorhinal cortex, which is the major provider of glutamatergic innervation to the hippocampus, significantly attenuated the elevation of adrenocorticotropic hormone (ACTH) in plasma during immobilization stress. In the present study, we examined the effects of microinjections of glutamatergic agonists into the hippocampus on plasma ACTH and glucose concentrations. We also studied the interactions between glutamate and acetylcholine in this response in the hippocampus.
MATERIALS AND METHODS: NMDA and AMPA subtypes of glutamate agonists were microinjected into the rat hippocampus, and ACTH and glucose levels in plasma were measured. The interaction between cholinergic and glutamatergic systems was investigated pharmacologically.
RESULTS: Both the NMDA and AMPA subtypes of glutamate agonists induced elevations of plasma ACTH and glucose levels in a dose-dependent fashion. These responses were independent of those induced by activation of the hippocampal cholinergic system.
CONCLUSION: Stimulation by the NMDA and AMPA subtypes of glutamate receptors in the hippocampus induced elevations of plasma ACTH and glucose, and these responses were independent of the cholinergic system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807523

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  3 in total

1.  Blocking AMPA receptor signalling by caroverine infusion does not affect counter-regulation of hypoglycaemia in healthy men.

Authors:  J Klement; I Pais; M Hallschmid; C Hubold; A Knispel; K M Oltmanns; B Schultes; J Born; A Peters
Journal:  Diabetologia       Date:  2009-04-03       Impact factor: 10.122

Review 2.  Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.

Authors:  Mark J Millan
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

3.  Immunomodulatory effects of domoic acid differ between in vivo and in vitro exposure in mice.

Authors:  Milton Levin; Heather Leibrecht; James Ryan; Frances Van Dolah; Sylvain De Guise
Journal:  Mar Drugs       Date:  2008-12-22       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.